← United States · All US Insider Profiles
US INSIDER PROFILE · NON-SCORING RESEARCH
Thermopylae Holdings Ltd.
10% Owner
Identity: SEC reporting-owner CIK · Reporting-owner CIK: 0001834449
Purchase history
- Companies traded
- 1
- Purchases · 12M
- 2
- Purchases · 24M
- 3
- Average purchase
- $484.4K
- Median purchase
- $580.3K
- Gross purchase value
- $1.5M
Companies: AbCellera Biologics Inc.
3 SEC accession(s) · 0 joint-owner event(s). Values are reported Form 4 transaction values in USD.
Qualifying purchase disclosures
| Published | Company | Ticker | Role | Reported value | SEC source |
|---|---|---|---|---|---|
| 2026-03-02 | AbCellera Biologics Inc. | ABCL | 10% Owner | $130.7K | Open filing |
| 2026-02-27 | AbCellera Biologics Inc. | ABCL | 10% Owner | $580.3K | Open filing |
| 2025-03-11 | AbCellera Biologics Inc. | ABCL | 10% Owner | $742.2K | Open filing |
Post-purchase outcomes
Excess return = stock return − S&P 500 ETF (SPY adjusted close) return. Returns start on the first shared trading session on or after publication.
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 3Small Sample | 100.0% (3/3) | 33.3% (1/3) | -2.4% | -1.6% | -6.7% |
| 20D | 3Small Sample | 100.0% (3/3) | 0.0% (0/3) | -3.0% | -3.9% | -6.5% |
| 60D | 3Small Sample | 100.0% (3/3) | 66.7% (2/3) | +32.8% | +23.0% | -0.7% |
| 120D | 3Small Sample | 100.0% (3/3) | 100.0% (3/3) | +184.2% | +152.9% | +65.8% |
Research patterns
- First purchase in 12M
- 0/2
- Large purchase ≥ $100k
- 3/3
- Cluster buying · 15D
- 3/3
- Buying the dip
- 3/3
Routine / opportunistic: Not classifiable. These labels never affect the score or ranking.
Small samples remain visible but are not scored. This research enrichment never affects US-v1.1.